NNOX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Nano-X Imaging (NNOX) Investors of Securities Class Action Lawsuit Deadline on August 11, 2026

If you purchased or acquired securities in Nano-X between March 31, 2025 and April 17, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) . New York, New York--(Newsfile Corp. - July 31, 2026) - Faruqi & Faruqi, LLP , a leading national securities law firm, is investigating potential claims against Nano-X Imaging Ltd. ("Nano-X" or the "Company") (NASDAQ: NNOX) and reminds investors of the August 11, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com . As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Defendants overstated purported efficiency gains achieved in Nano-X's operations, as well as the purported increased demand for its products; (2) in reality, Nano-X's production and manufacturing operations were poorly aligned with demand for the Company's products; (3) as a result, Nano-X was experiencing significantly increased operating expenses and cash burn; (4) the foregoing significantly increased the likelihood that Nano-X would be forced to take disruptive remedial measures with respect to its manufacturing operations, entailing significant restructuring and impairment charges; and (5) as a result, Defendants' public statements were materially false and misleading at all relevant times. On April 20, 2026, Nano-X issued a press release announcing its fourth quarter 2025 financial results and providing a business update. Among other items, Nano-X reported a net loss of $33.4 million for the quarter, mainly due to a $17.5M charge attributed to impairment of long-lived assets following a restructuring initiative at its Korean chip manufacturing facility. Nano-X also announced that CFO Ran Daniel would step down from that role on July 31, 2026. On this news, Nano-X's stock price fell $0.6950 per share, or 24.39%, to close at $2.1550 per share on April 20, 2026. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Nano-X's conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the Nano-X Imaging class action, go to www.faruqilaw.com/[NNOX](/en/us/NNOX) or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) . The lawsuit alleges Nano-X Imaging misled investors about operational efficiency, product demand, manufacturing performance, and costs. Plaintiffs claim the company understated cash burn, rising expenses, and risks of restructuring and impairment charges.